Protective role of melatonin against adipose-hepatic metabolic comorbidities in experimentally induced obese rat model
Sign Up to like & getrecommendations! Published in 2021 at "PLoS ONE"
DOI: 10.1371/journal.pone.0260546
Abstract: Background Adipose and hepatic metabolic dysfunctions are critical comorbidities that also aggravate insulin resistance in obese individuals. Melatonin is a low-cost agent and previous studies suggest that its use may promote metabolic health. However, its… read more here.
Keywords: melatonin; group received; adipose hepatic; hepatic metabolic ... See more keywords